Agencourt Bioscience Corporation is a provider of genomic services and nucleic acid purification products that help biotech and pharmaceutical companies improve the effectiveness and efficiency of their drug development pipelines. Agencourt's Discovery Solutions™ suite of genomic and functional genomic services includes high-throughput sequencing, SAGE™ sequencing, library construction and SNP discovery. The company's purification products and services are based on the proven and patented Solid Phase Reversible Immobilization (SPRI™) technology, which has been adopted by several of the largest genome research facilities, resulting in more base pairs contributed to GenBank than any other nucleic acid purification technology and used to sequence over one-third of the human genome. Agencourt was recently the sole commercial sequencing provider to be designated by the National Human Genome Research Institute (NHGRI) as one of five Large-Scale Sequencing Centers. The company has also been confirmed to be operating in compliance with the requirements of the Good Laboratory Practices (GLP) as a contract analytical laboratory. Agencourt is located in Beverly, Massachusetts and is available on the Web at www.agencourt.com.

products: Agencourt Bioscience Introduces New Reagent For Genomic DNA Isolation
Isopure™ Buccal Cell Genomic DNA Purification Kit Expands Company's SPRI® Magnetic Bead Technology into New Markets more

Contact address
Agencourt Bioscience Corporation
500 Cummings Center, Suite 2450
Beverly MA, 01915
Driving directions

Sales 800-361-7780
Office 978-867-2600
Fax 978-867-2601

General Information webinfo@agencourt.com
Sales Inquiry websales@agencourt.com
Customer Support websupport@agencourt.com
Human Resources hr@agencourt.com